Close this search box.

Reference Hub

340B Drug Pricing Program

In 2014, the National Hemophilia Program Coordinating Center (NHPCC) conducted the first-ever national survey to assess the impact of the 340B drug pricing program on the capacity of hemophilia treatment centers to deliver services.

Author(s): NHPCC

Date: 2014

Document Type: Printed Materials

Updated on March 5, 2023
Enter your search criteria to find works by title, author, keyword(s), or date.